1. abiraterona 500 mg – inhibidor de la CYP17 en cáncer de próstata metastásico resistente a castración
  2. Track

abiraterona 500 mg – inhibidor de la CYP17 en cáncer de próstata metastásico resistente a castración

Primary tabs

Time ReferrerUserOperations
08/25/2025 - 23:58node/7427/trackAnonymous (not verified)details
08/25/2025 - 21:44node/7427/trackAnonymous (not verified)details
08/25/2025 - 20:24node/7427/trackAnonymous (not verified)details
08/25/2025 - 17:41node/7427/trackAnonymous (not verified)details
08/25/2025 - 17:39node/7427/trackAnonymous (not verified)details
08/24/2025 - 14:36node/7427/trackAnonymous (not verified)details
08/24/2025 - 05:24node/7427/trackAnonymous (not verified)details
08/23/2025 - 15:45node/7427/trackAnonymous (not verified)details
08/23/2025 - 14:26node/7427/trackAnonymous (not verified)details